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mong the 50 to 60 million individuals suffering
from epilepsy worldwide,up to one third might develop
pharmacoresistance.
1 In a subset of this population,
epilepsy surgery represents the optimal treatment option.
However,the proportion of drug-resistant patients who
could or should be offered a surgical treatment remains
largely unknown,with estimates varying from 5% to 50%
of all cases of drug-resistant epilepsies.This uncertainty
reflects a lack of appropriate studies,and disagreements
regarding the criteria that best define an epilepsy surgery
candidate,as well as the major gap between the number
91
Clinical research
Copyright © 2008 LLS SAS.  All rights reserved www.dialogues-cns.org
Epilepsy surgery: eligibility criteria and
presurgical evaluation
Philippe Ryvlin, MD, PhD; Sylvain Rheims, MD
A
Keywords: refractory epilepsy, epilepsy surgery, presurgical evaluation, video-
EEG, MRI, PET, SPECT, MRS, MEG, fMRI, invasive EEG recording
Author affiliations: Department of Functional Neurology and Epileptology,
Neurological Hospital, CTRS-INSERM IDEE (Institut Des Epilepsies de l’Enfant
et de l’adolescent), Hospices Civils de Lyon, INSERM U821, Université Claude
Bernard Lyon 1, Lyon, France  
Address for correspondence: Philippe Ryvlin, Unité 301, Hôpital Neurologique,
59 bd Pinel, 69003, Lyon, France
(e-mail: ryvlin@cermep.fr)
Epilepsy surgery has benefited from major advances during the last 20 years, thanks to the development of neuroimag-
ing and long-term video-electroencephalographic (EEG) monitoring. However, it remains the case that only a small minor-
ity of potential epilepsy surgery candidates will have access to a comprehensive presurgical evaluation. Furthermore, this
subset of patients are operated on after an average of 20 to 25 years of epilepsy duration. Among the various reasons
that prevent many patients from benefiting from a timely presurgical evaluation, we need to emphasize the role of inac-
curate information regarding eligibility criteria and lack of standardized practice. This review aims at providing an in-
depth discussion of the current views regarding the definition of surgical candidates, and the role of the numerous inves-
tigations used in the presurgical evaluation of patients with drug-resistant epilepsy. 
The eligibility criteria required to enter a presurgical evaluation in 2008 should be relatively liberal, provided that the
patient suffers from disabling seizures unrelated to an idiopathic generalized epileptic syndrome, despite appropriate
antiepileptic drug treatment. However, the decision as to whether or not to perform a presurgical evaluation must be
individualized, and take into account the likelihood of meeting the patient’s expectations in terms of outcome. These
expectations need to be balanced with the apparent severity of the epileptic condition, the chance of achieving a suc-
cessful surgical treatment, and the risk of a postoperative neurological, cognitive, or psychiatric deterioration. 
The roles and specific features of the main types of presurgical investigations are reviewed. 
© 2008, LLS SAS Dialogues Clin Neurosci. 2008;10:91-103.of these potential candidates and that of patients that are
actually operated on.
2
Furthermore,the majority of patients who are eventually
operated on are referred for surgery after an average of
20 to 25 years of epilepsy duration.
3,4This delay is likely
responsible for a significant number of avoidable seizure-
related deaths,including drowning,motor vehicle acci-
dent, fatal status epilepticus (SE), and sudden unex-
pected death in epilepsy (SUDEP),the rate of which is
about 1% per year in patients with drug-resistant
epilepsy.
5 In addition,the longer the delay between the
onset of drug-resistant epilepsy and surgery,the lower the
chance of postoperative seizure freedom and improved
socioprofessional outcome.
4,6,7This issue is further aggra-
vated by the 1- to 2-year waiting list for entering a presur-
gical evaluation program in the majority of epilepsy
surgery centers.
Several reasons underlie the above situation,including
the patients’ and physicians’ legitimate fear of a postop-
erative permanent neurological deficit, the frequently
insidious course of chronic epilepsy,
8 the relatively low
yield of long-term postoperative seizure freedom (~ 60%
after 10 years of follow-up),
9 the paucity of randomized
control trials (RCTs) demonstrating the efficacy of sur-
gical therapy over antiepileptic drugs (AEDs),
10 the com-
plexity and heterogeneity of surgical treatments,and the
limited resources dedicated to the presurgical evaluation
of epilepsy patients.
Some of these reasons can now be challenged. For
instance,major safety progress has been made in the field
of neurosurgery, with a risk of unexpected vascular or
infectious complications resulting in a residual disabling
neurological impairment of about 1% in experienced
epilepsy surgery groups.
2,11 Thus, the risk of seizure-
related death or serious injury in drug-resistant patients
refusing epilepsy surgery (about 1% per year),is signifi-
cantly higher than the major morbidity/mortality associ-
ated with surgical treatment (about 1%in total).The sub-
optimal yield of postoperative long-term seizure freedom
must also be balanced with the much worse figures
reported in patients who have not been operated on,only
5% to 14% of whom will achieve seizure remission.
12,13
Altogether,the available data in the literature strongly
suggest that epilepsy surgery is significantly more effica-
cious than medical treatment.
Eligibility criteria for presurgical evaluation
and epilepsy surgery
Patient selection for epilepsy surgery is a two-step pro-
cedure that first aims to identify potential surgical can-
didates who should benefit from a presurgical evaluation,
and then to determine in each assessed individual
whether the risk:benefit ratio for surgery is acceptable.
Three main criteria must be fulfilled to enter the first
step:(i) the patient (or his or her parents for young chil-
dren and patients with intellectual impairment) needs to
understand the objective of the presurgical evaluation
and to agree on the possibility of a surgical treatment;(ii)
the patient should suffer from disabling seizures despite
appropriate medical therapy;and (iii) available imaging
and electroclinical data should be consistent with the pos-
sibility of a surgically remediable epileptic syndrome.
The first criterion is minor,but should not be overlooked,
since it often represents a limiting factor in patients who
would otherwise be considered good surgical candidates.
The second criterion relies on the definition of disability
and drug resistance.The assessment of disability must
take into account a number of objective parameters,such
as seizure frequency and severity,AED side effects,and
also the socioprofessional and familial impact of the dis-
ease,and the patient’s subjective rating of his or her over-
all handicap.The patient’s perception that his or her dis-
ability is worth taking the risk of a surgical treatment
plays a major role in deciding to proceed to a presurgical
evaluation.However,this judgment is not always based
on realistic expectations of postoperative outcome,and
thus needs to be balanced with the physician’s more
objective view of the risk:benefit ratio of epilepsy
surgery. Regarding drug resistance, there is a general
agreement to consider a patient medically refractory if
two or more appropriately selected and managed AEDs
failed to control his or her seizures.
14 Indeed, once a
patient has not responded to the first two drugs,the like-
lihood of achieving sustained seizure freedom with any
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Selected abbreviations and acronyms
AED antiepileptic drug
DA dopamine
EEG electroencephalogram
EZ epileptogenic zone
GABA -aminobutyric acid
MRI magnetic resonance imaging
PET positron-emission tomography
SPECT single photon-emission computed tomography
TLE temporal lobe epilepsyother medical treatment is less than 5%.
15A 2-year fol-
low-up is also usually required to conclude on the pres-
ence of a refractory epilepsy in adult patients.However,
shorter epilepsy duration can be accepted in epileptic
children with catastrophic epilepsies.
2
The third criterion to be considered,ie,the identification
of a surgically remediable epileptic syndrome,has been
classically defined as the presence of a symptomatic or
cryptogenic localization-related epilepsy, whose sus-
pected underlying epileptogenic zone (EZ) should be
unique,and not overlapping with eloquent brain regions.
However,important progress has been made in the field,
allowing widening of the scope of epileptic syndromes
amenable to surgery.These now include patients with
various forms of symptomatic generalized epilepsies,
such as infantile spasms associated with cortical dyspla-
sia,
16,17 seemingly multifocal partial epilepsy related to
tuberous sclerosis,
16,18 EZ involving eloquent areas,
19,20
Landau-Kleffner syndrome,
16 and patients combining a
surgically remediable partial epilepsy and an idiopathic
generalized epileptic syndrome with the hope of curing
the former with surgery, allowing a more appropriate
AED regimen to control the latter.
21 In addition,pallia-
tive surgical treatments, such as callosotomy and deep
brain stimulation,can be proposed in patients with other
forms of severe cryptogenic or symptomatic generalized
epilepsies,including Lennox-Gastaut syndrome.
22
To summarize,the eligibility criteria required to enter a
presurgical evaluation in 2008 should be relatively liberal,
provided that the patient suffers from disabling seizures
unrelated to an idiopathic generalized epileptic syndrome,
despite appropriate AED treatment.However,the deci-
sion as to whether or not to perform a presurgical evalua-
tion must be individualized,and must take into account
the likelihood of meeting the patient’s expectations in
terms of outcome.These expectations need to be balanced
with the apparent severity of the epileptic condition,the
chance of achieving a successful surgical treatment,and
the risk of a postoperative neurological,cognitive,or psy-
chiatric deterioration.The same questions arise once the
presurgical evaluation has been completed, in order to
decide on a surgical treatment,though the weight placed
on each of the above parameters is likely to vary towards
more stringent criteria (ie,more severe epilepsy,greater
will of the patient to take the risk of surgery given a clear
understanding of his or her individual prognosis,higher
chance of achieving postoperative seizure freedom,lower
risk of postoperative deterioration).The gap between eli-
gibility criteria used for entering a presurgical evaluation
and those applied to deciding on a surgical treatment
determines the proportion of patients assessed for surgery
who will be operated on, eventually. This proportion,
together with the profiles of surgical candidates,largely
varies between epilepsy surgery centers,as a function of
their experience and culture.For instances,some centers
focus on temporal lobe epilepsy (TLE) surgery whereas
other develop specific expertise in catastrophic epilepsies
of childhood,extratemporal partial epilepsies,cryptogenic
cases,or operations in eloquent brain regions.
Presurgical evaluation
The primary aim of the presurgical evaluation is to iden-
tify the EZ,ie the minimum amount of brain tissue that
should be resected to render the patient seizure-free.At
the present time, none of the available investigations
allows direct delineation of the EZ.Thus,the identifica-
tion of the EZ results from the integration of the follow-
ing information: the sequence of ictal signs and symp-
toms that defines the symptomatogenic zone,the brain
regions that generate interictal electroencephalographic
(EEG) epileptiform discharges (so-called irritative zone),
the ictal onset zone corresponding to the region of EEG
seizure onset,and the epileptogenic lesion disclosed by
magnetic resonance imaging (MRI).
23Two other regions
need to be identified to ensure a safe and optimal surgi-
cal treatment, ie, eloquent cortex and the functional
deficit zone.Finally,several indicators of postoperative
outcome need to be gathered to anticipate the chance of
successful epilepsy surgery.
Three types of investigations should be distinguished:(i)
those considered mandatory for every patient, which
include a detailed past history and description of seizures
by the patient and his or her relatives,interictal scalp EEG
data,and an optimal brain MRI unless contraindicated;(ii)
long-term video-EEG monitoring that allows capture of
the patient’s seizure is also considered a mandatory inves-
tigation in the majority of epilepsy surgery centers, but
some groups argue that it might be skipped in a minority
of patients;and (iii) all other investigations that are either
used in selected patients in most epilepsy surgery centers,
or in some centers only.Invasive EEG recordings and the
Wada test illustrate the former situation,whereas positron-
emission tomography (PET),ictal single photon-emission
computed tomography (SPECT), and magnetoen-
cephalography (MEG) are examples of the latter.
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A detailed interview of the patient and his or her parents,
relatives, or friends who have witnessed the seizures
remains the cornerstone of the presurgical evaluation.This
interview should recapitulate all relevant past history and
provide the most detailed description of the patient’s
seizure.For instance,lateralized and prolonged febrile con-
vulsions are likely to be associated with a temporal lobe
EZ contralateral to the side of convulsions,and with an
excellent seizure outcome following TLE surgery.
9,24
Conversely a severe herpes virus meningoencephalitis is
more likely to result in multifocal or bilateral drug-resis-
tant epilepsy not amenable to successful surgical treat-
ment.
25,26 Family history of neurological and epileptic dis-
orders must also be sought, and may help to identify a
specific syndrome,such as autosomal dominant nocturnal
frontal lobe epilepsy (NFLE)
27 or TLE,
28 or forme frustre
of tuberous sclerosis.
29 A detailed assessment of the
patient’s hand,eye,and foot dominance,together with the
description of his or her ictal and postictal language abil-
ities, allows inference regarding the most likely side of
seizure onset. Stereotyped auras that can be precisely
described by the patient often represent one of the most
reliable indicators of the seizure onset zone.This is partic-
ularly true for elementary sensory or motor signs pointing
to the corresponding primary or secondary cortical areas,
but also for rising epigastric sensation,déjà vu, déjà vécu,
and dreamy state that strongly suggest a temporal lobe
seizure onset. However, like any other ictal symptom,
auras might only reflect the propagation into the sympto-
matogenic zone of an epileptic discharge that has origi-
nated in a distant silent brain region.It is also essential to
assess the presence and frequency of secondary general-
ization,since the latter supports an extratemporal EZ and
predicts a poor outcome following temporal lobe surgery.
6
A comprehensive cognitive and psychiatric evaluation is
likely to provide useful information.Some neuropsycho-
logical dysfunctions are associated with specific EZ,such
as verbal memory impairment with left TLE.
30 More
importantly, the degree of preoperative verbal memory
impairment is a strong predictor of postoperative memory
decline following surgery in the dominant temporal lobe.
31,32
The lower the preoperative impairment, the greater the
risk of postsurgical deterioration.In addition,diffuse neu-
ropsychological deficits may be an indicator of extensive
brain disease and therefore a marker of poor outcome fol-
lowing focal resection.
33,34The prevalence of psychiatric dis-
orders in patients referred to epilepsy surgery might be as
much as 80%.
35Whether these disorders increase the risk
of postoperative seizure recurrence remains controver-
sial.
36,37 Likewise,they do not necessarily predict the risk of
postoperative psychiatric complications,except maybe for
personality disorders.
38-40Thus,mental disorders do not pre-
clude epilepsy surgery. Nevertheless, their appropriate
assessment by a psychiatrist with specific expertise in
epilepsy might help to anticipate acute anxiety,delusions,
or aggressive behavior during long-term EEG monitoring
(in particular following a cluster of seizures favored by the
tapering of AEDs during invasive EEG monitoring),and
in the immediate postoperative period (in particular fol-
lowing right temporal lobectomy).
41 In addition, such
assessment allows better evaluation of the patient’s under-
standing of,and expectations from,the presurgical workup,
and whether these are in line with the reality.
Interictal EEGs often demonstrate epileptiform discharges
in patients with drug-resistant epilepsy,providing impor-
tant hints regarding the lateralization and localization of
the EZ. However, these abnormalities might be falsely
localizing in a minority of cases.In TLE,the presence of
unilateral anterior temporal spikes is a strong predictor of
postoperative seizure freedom,whereas the lack of epilep-
tiform discharge and bilateral abnormalities are associated
with poorer prognosis.
24 Nevertheless,bitemporal spikes,
either synchronous or independent from each other,do
not preclude successful temporal surgery,provided that
they predominate on the side to be resected.
42 Similarly,
multifocal and generalized epileptiform discharges are
compatible with successful surgery in children presenting
with an epileptogenic unilateral brain lesion,
17 as well as in
patients with tuberous sclerosis.
43 Specific EEG patterns,
characterized by well localized repetitive fast spikes asso-
ciated with short burst of low-voltage, high-frequency
oscillations might help to suspect an underlying MRI-
occult focal cortical dysplasia.
44
An optimal high-resolution MRI is of paramount impor-
tance to detect a structural abnormality most likely
responsible for the seizure disorder.It is clear that the
EZ might often extend outside the MRI-detected bor-
ders of such abnormality,and that epilepsy surgery can
be successfully performed in patients with a normal
MRI.
45-47 However,in the great majority of patients who
have been operated on,MRI discloses an epileptogenic
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and surgical strategy.Indeed,other investigations will pri-
marily assess the relationship between seizures and the
MRI lesion, the amount of abnormal brain tissue and
surrounding cortex included in the EZ,and the possibil-
ity of surgically removing part or all of the lesion and
associated epileptogenic cortex.This framework is simi-
larly applied to hippocampal sclerosis,malformation of
cortical development, scars of various origins, and any
space-occupying lesion.The quality of the MRI investi-
gation has a major impact on its sensitivity.Those per-
formed by neuroradiologists with specific expertise in the
field of epilepsy surgery have the highest detection rate.
48
Three-dimensional T1-weighted images,as well as T2 and
fluid attenuated inversion recovery (FLAIR) sequences,
need to be performed using appropriate slice thickness
and orientation.In TLE,coronal cuts perpendicular to
the long axis of the hippocampus are required to cor-
rectly assess the presence of hippocampal atrophy and
gliosis.Gradient echo sequences can be useful to detect
small cavernous angiomas,whereas gadolinium should
be used when a tumor is observed or suspected.Recent
reports suggest that the use of 3-Tesla magnets increases
the detection rate of subtle epileptogenic lesions,includ-
ing focal cortical dysplasia.
49
Long term video-scalp EEG monitoring
In the majority of surgical candidates,video-EEG moni-
toring plays an essential role in the presurgical evaluation,
by providing a detailed description of ictal clinical signs and
EEG discharge,as well as prolonged interictal recordings.
We have previously commented on the value of ictal semi-
ology and interictal EEG abnormalities. Ictal EEG also
provides valuable lateralizing and localizing information
with regard to the ictal onset zone.
50,51 However,it might be
misleading in patients with a deeply located focus (ie,
mesial frontal,parietal,occipital,or insular),by either fail-
ing to detect a clearcut epileptic discharge,or by only show-
ing the seizure spread to distant cortical areas.
52,53
In rare instances,a surgical decision might be taken with-
out a video-EEG recording of seizures.This applies to
patients with simple partial seizures that perfectly match
with the location of a focal epileptogenic lesion involv-
ing the corresponding primary sensory or motor cortex,
a situation where the information provided by the video-
scalp EEG recording of seizure is unlikely to influence
the surgical strategy.
Optional investigations
Three major caveats must be considered when discussing
the utility of these presurgical investigations:
1.None of these diagnostic tools has been properly evalu-
ated through RCTs whose primary end point should be
their impact on the proportion of patients successfully
operated.In 2006,the Health Technological Assessment
(HTA) program of the UK National Health Service
(NHS) published a comprehensive “systematic review of
the effectiveness and cost-effectiveness of neuroimaging
assessments used to visualise the seizure focus in people
with refractory epilepsy being considered for surgery.”
54
Their main conclusion was that “Due to the limitations
of the included studies,the results of this review do little
to inform clinical practice, with insufficient evidence
regarding effectiveness and cost-effectiveness of imaging
techniques in the work-up for epilepsy surgery.”
2.There is no consensus regarding the optimal gold stan-
dard that should be used for assessing the performance
of these presurgical investigations. Invasive EEG
recording has been used in some studies,but it faces
several limitations, including a variety of techniques
(subdural grids versus depths electrodes),limited spa-
tial sampling, investigator dependent placement of
electrodes,population bias,and a potential for misdi-
agnosis.Postoperative seizure freedom is another pos-
sible gold standard that also raises a number of issues,
such as the time elapsed between surgery and the last
follow-up,the postoperative management of AED reg-
imen, the quality of the surgical procedure, and the
complex process through which an investigation might
interact with the surgical strategy.
3.Last but not least,there is a great heterogeneity in the
way presurgical data are analyzed, most notably for
functional neuroimaging.Visual analysis is much less
reproducible for such data than it is for structural MRI,
whereas more objective assessments,using regions of
interest (ROIs) or statistical parametric mapping
(SPM),are highly sensitive to a number of parameters
that largely varied among centers.
Though we fully endorse the conclusions of the NHS
R&D HTA program regarding the need of an appropri-
ate assessment of presurgical investigations,we feel that
such an effort is unlikely to be developed for the major-
ity of available techniques in the near future.Thus, we
still need to primarily rely on our judgment to define the
strategy of an optimal presurgical evaluation.
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The most commonly used tracer is 
18F-fluorodeoxyglucose
(FDG) whose brain accumulation reflects the local cere-
bral metabolic rate of glucose.Many studies have shown
that in the interictal period,decreased glucose metabolism
is usually observed within the lobe of seizure onset.
Furthermore,comparisons between FDG-PET and inva-
sive EEG data have demonstrated that the hypometabolic
areas often overlap with the region of ictal onset.
55-57
However,areas of hypometabolism are often larger than
the epileptogenic zone, and might not necessarily pre-
dominate over the latter.
58Whether the extent of hypome-
tabolism outside the temporal lobe represents a risk fac-
tor for postoperative seizure recurrence after anterior
temporal lobectomy is a matter of debate.
59-61The above
issues account for the lack of consensual practical guide-
lines regarding the clinical indications of FDG-PET in the
presurgical evaluation of patients with drug-resistant
epilepsy.
54,62-64There is,however,some consensus that the
lack of detectable interictal hypometabolism in patients
contemplating temporal lobe surgery is associated with a
poor seizure outcome.
65-67This finding might be particularly
relevant in TLE patients with a normal MRI. Indeed,
excellent seizure outcome was reported in that population,
provided FDG-PET abnormalities were present.
45 More
generally,FDG-PET in patients with a seemingly normal
MRI might help to disclose subtle morphological abnor-
malities,including focal cortical dysplasia.Thus,despite the
lack of official recommendation,it seems reasonable to
offer FDG-PET,at least to surgical candidates whose MRI
is normal.
[
11C]Flumazenil (FMZ) PET allows measurement of the
apparent density of the γ-aminobutyric acid (GABA)A
receptor allosteric site for benzodiazepine (BZD),which
is typically reduced in epileptogenic foci.
68 This abnor-
mality is thought to primarily reflect neuronal loss,
69 but
its fluctuation over time observed in patients scanned
twice also suggest underlying functional disturbances of
the GABA)A receptor complex.
70,71 FMZ-PET has also
been extensively evaluated in patients with drug-resis-
tant partial epilepsy,and has consistently demonstrated
more focal abnormalities than FDG-PET.
72 However,the
issue as to whether FMZ-PET allows a more precise
delineation of the epileptogenic zone than FDG-PET
remains a matter of debate.
55,73 In particular,in patients
with a normal MRI,FMZ-PET might suffer a higher rate
of negative or falsely localizing findings than FDG-
PET.
55,70,71,74 Finally,in patients with TLE and MRI signs
of hippocampal sclerosis, FMZ-PET might disclose
periventricular white matter increased binding of
[
11C]Flumazenil,thought to reflect microscopic hetero-
topia,which were found associated with poor postoper-
ative seizure outcome.
75This finding,if replicated,could
support the clinical utility of FMZ-PET as a prognostic
tool in TLE patients contemplating surgery.
In patient with tuberous sclerosis and multiple tubers,
PET using [
11C]alpha-methyl-L-tryptophan (AMT)
appears to be the only interictal imaging investigation
that can specifically identify which of the multiple tubers
is responsible for the seizure disorder, by showing an
increased AMT uptake within that tuber.
76 However,this
pattern is only observed in half of the patients.
77-79
More recently,several studies have used different mark-
ers of 5-HT1A receptors in patients with drug-resistant
TLE, including [
11C]WAY100635, [
18F]FC-WAY, and
[
18F]MPPF,and consistently showed major decreased of
binding potential within the epileptogenic temporal
lobe.
80-83 Whether these PET investigations will prove
more clinically useful than,or complementary to,FDG
and FMZ-PET remain to be elucidated.
Ictal SPECT
Ictal SPECT remains the only imaging method that can
routinely capture clinically overt seizures,regardless of the
patient ictal movements. The most typical pattern
observed on ictal SPECT images is a focal area of hyper-
perfusion,thought to reflect the ictal discharge,with sur-
rounding hypoperfusion.The delineation of these abnor-
malities is optimized by subtracting interictal from ictal
SPECT images from the same patient,and coregistering
the resulting data on his or her MRI (subtraction ictal
SPECT coregistered with MRI, SISCOM).
84 Recent
attempts to detect significant ictal hyperperfusion by com-
paring ictal SPECT to a database of interictal SPECT per-
formed in normal subjects also proved promising.
85The
earlier the timing of injection after seizure onset,the more
sensitive and reliable the results of ictal SPECT.
Like FDG-PET abnormalities, ictal hyperperfusion is
likely to reflect the impact of the ictal discharge in
regions of seizure onset and propagation.
86 However,it is
assumed that the epileptic discharge is more sustained
within the epileptogenic zone,and that this should trans-
late into greater hyperperfusion in this region than in
areas of seizure propagation. This is only partly con-
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ison of ictal SPECT data with that of other investigations,
including intracranial EEG recordings and surgical
results. Indeed, a few papers have looked at the corre-
spondence between the ictal onset zone as defined by
invasive EEG investigation,and ictal hyperperfusion,and
reported variable degrees of concordance or overlap
between the two.
87According to these results,the role of
ictal SPECT in surgical candidates who would otherwise
require intracranial EEG recordings seems rather to help
optimize the placement of the intracranial electrodes
than to replace this invasive investigation.
88,89 For
instance,in a recent series of 26 patients who benefited
from SISCOM and subsequent invasive EEG,the former
was found to modify the placement of intracranial elec-
trodes in 58% of cases.
88
Like FDG-PET,ictal SPECT might also help to detect
subtle focal cortical dysplasia not readily detectable on
MRI,
90 and to predict the chance of postoperative seizure
freedom.
91,92 In particular,in patients with a normal MRI
or an extensive malformation of cortical development,
the more complete the resection of the brain region
showing ictal hyperperfusion,the better the surgical out-
come.
91,92 However,a complete resection of the SISCOM
focus does not seem to be mandatory to achieve com-
plete seizure freedom in patients with focal cortical dys-
plasia.
90
As detailed above, the potential clinical utility of ictal
SPECT appears to primarily lie in patients with a normal
MRI as well as in the prediction of surgical outcome,two
issues that have also proved to be the most relevant clin-
ical indications for FDG-PET. The two investigations
have been directly compared with each other in several
studies.
56,57,93-96They appear to provide comparable local-
izing information in a majority of cases,but can also point
at strikingly different regions in a minority of patients.
56,57
Ictal SPECT might be more sensitive than FDG-PET in
epileptogenic zones involving the parietal and occipital
lobes,
94 and more appropriate for evaluating the epilep-
togenicity of large malformation of cortical develop-
ment.
91 Conversely, in one of the largest studies of
patients with a normal MRI,FDG-PET was found to be
superior to ictal SPECT for predicting postoperative
seizure outcome.
57 Furthermore, FDG-PET remains
more readily available than ictal SPECT in most epilepsy
surgery centers.At the present time,there is no consen-
sus regarding the clinical situations where these two
investigations should be combined.
1H magnetic resonance spectroscopy
1H magnetic resonance spectroscopy (MRS) has been
assessed much less extensively than PET and SPECT,
and primarily in patients with TLE.This technique suf-
fers two main drawbacks,a relatively poor spatial reso-
lution (though the later has increased from 8 cm
3 voxels
in the earlier studies to 1 cm
3 voxels at present), and a
limited spatial sampling of the brain that requires an a
priori hypothesis regarding the localization of the epilep-
togenic zone.In TLE,1H MRS typically demonstrates
reduced N-acetyl aspartate (NAA)/choline and creatine
ratio in the epileptogenic temporal lobe,often associated
with less marked contralateral abnormalities.
97-99 This
finding was also observed in patients with MRI-negative
TLE.
97,99-101The few studies performed in extratemporal
epilepsies have also reported reduced NAA/choline and
creatine ratio in the epileptogenic zone,as well as in the
irritative zone.
102-104
According to all above findings,and the technical limita-
tions of 1H MRS,it appears that the primary clinical util-
ity of this investigation would be the prediction of post-
operative seizure outcome in TLE patients, especially
those with a normal MRI or bilateral hippocampal atro-
phy.
100,105-107 However, it still needs to be demonstrated
whether H1 MRS is an independent predictor of surgi-
cal outcome,taking into account all other relevant clini-
cal and imaging data.
Magnetoencephalography
The technology of multichannel magnetoencephalogra-
phy (MEG) has considerably improved over the last 10
years,with a dramatic increase in the number of record-
ing channels,up to 300 sensors,
108 and the development of
more efficient data analysis using magnetic source imag-
ing (MSI) and spatial filtering by means of synthetic
aperture magnetometry (SAM).
109 This development
necessitates  revisiting the clinical utility of MEG in the
presurgical evaluation of patients with epilepsy,
110 though
the main limitation of MEG remains its lack of avail-
ability in the majority of epilepsy surgery centers.
MEG primarily detects interictal epileptiform discharges,
though in rare instances ictal recordings could be per-
formed.
111 It was found to be more sensitive than scalp
EEG,in particular for the detection of neocortical spikes,
but also more potent for delineating the maximal source
of interictal epileptiform discharges.
112 MSI was com-
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97pared with intracranial EEG recordings in 49 patients
and demonstrated a predictive positive value for seizure
localization of 82%.
113
Like FDG-PET,ictal SPECT,and 1H MRS,MSI might
also help to disclose a brain lesion not readily detectable
on MRI and to better predict postoperative seizure out-
come.
110,114,115The only study that has compared MEG and
FDG-PET demonstrated congruent findings in the
majority of patients.
116 MEG appears to have a more spe-
cific impact than the above investigations on the local-
ization of epileptogenic tuber,
117 and of spiking cortex
underlying Landau-Kleffner syndrome.
118 In addition,
MEG does not involve the inconvenience of injecting a
radioactive compound such as for PET and SPECT,nor
the distressing effect of MRI observed in some patients,
particularly children.
Though future studies are needed to thoroughly assess
the clinical utility of MEG compared with,or in associa-
tion with,other presurgical investigations,it seems rea-
sonable for centers that have access to this very safe pro-
cedure to use it without much restriction.
Functional MRI 
Functional MRI (fMRI) has proved reliable for mapping
eloquent areas in patients contemplating epilepsy
surgery. It can be used for localizing the sensorimotor
cortex or language areas when these functional brain
regions are at risk to be included in the EZ.However,if
a surgical resection is planned in the vicinity of fMRI-
activated brain regions,intraoperative cortical mapping
remains mandatory to more precisely assess the extent
of these eloquent areas. Several studies have demon-
strated that fMRI was also effective and reliable for the
lateralization of language dominance in patients with
epilepsy,
119,120 including one large series of 100 patients
where it was compared with the Wada test.
121
In the near future,fMRI may also replace the Wada test for
the assessment of memory capacities within each temporal
lobe.
122-125 One study that directly compared the two inves-
tigations concluded that fMRI more precisely anticipate
the postoperative memory decline than the Wada test.
122
fMRI might also be used in combination with scalp EEG
to detect focal BOLD activation induced by interictal
epileptiform discharges, subclinical seizures, or pau-
cisymptomatic ictal events.
126-128 Sophisticated data analy-
sis,such as temporal cluster analysis,might also demon-
strate focal BOLD signal abnormalities supposedly
reflecting interictal epileptiform activity,without neces-
sitating concomitant EEG recording.
129 However, the
clinical utility of these developing techniques remains to
be evaluated.
Intracarotid amytal test or Wada test
The Wada test has been extensively used in the past for
assessing the side of language dominance and the risk of
memory decline following temporal lobe surgery.
130As
previously discussed,its utility for lateralizing language
areas has now been challenged by fMRI. For memory
assessment,where fMRI remains to be fully validated,
the Wada test appears to be primarily useful in patients
with left (dominant) TLE.
131
Intracranial EEG 
Intracranial EEG recording remains a mandatory investi-
gation in a significant proportion of epilepsy surgery can-
didates, in order to ensure the delineation of the EZ.
Though the precise criteria used to proceed to such inva-
sive recordings largely vary between centers,some general
recommendations can be made regarding this issue: (i)
intracranial EEG recording should tackle a specific
hypothesis regarding the localization of the EZ,and not
be performed as a “fishing expedition”;(ii) appropriate
candidates might include patients with a normal MRI,
patients with symptomatic extra-temporal lobe epilepsy
where a simple lesionectomy appears unlikely to control
seizures,and patients with a temporal lobe MRI abnor-
mality associated with atypical electroclinical features for
TLE, suggesting the possibility of temporal plus
epilepsy.
53,132 Two main types of invasive recordings are
available:subdural grids that are used in the great major-
ity of epilepsy surgery centers worldwide,and depth-elec-
trodes,including stereoelectroencephalography (SEEG),
that are primarily used in French and Italian centers.Both
techniques have specific advantages and drawbacks,and
suffer from limited spatial sampling. Subdural grids can
provide an accurate delineation of EZ located on the cor-
tical surface of the brain, whereas SEEG appears more
appropriate for investigating deeply located EZ,such as in
the insula,the mesial aspects of the frontal,temporal,pari-
etal,and occipital lobe,or the bottom of deep sulci.
52,132-136 In
any case,the placement of subdural or depth electrodes is
individualized according to all available presurgical data.
Complications of these invasive procedures are usually
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137 A large
number of relevant information can be provided by
intracranial EEG recordings, including interictal slow
waves, spikes, and bursts of high frequency oscillations,
ictal discharges,and responses to various types of electri-
cal cerebral stimulation.It was recently shown that abnor-
mal high frequency oscillations,including ripples and fast
ripples,either occurring at seizure onset or during interic-
tal bursts,were the most reliable marker of the EZ.
138-141
High- and low-frequency electrical stimulation of the sus-
pected EZ can be used to reproduce the patient’s ictal
signs and EEG discharges,and to test eloquent cortex.
Conclusions
Thanks to the advances of many investigations, an
increasing number of patients with drug-resistant
epilepsy can benefit from a conclusive presurgical eval-
uation that will hopefully lead to a successful surgical
treatment. Nevertheless, important progress still needs
to be achieved in order to assess the performance and
specific impact of these various investigations more rig-
orously.Large multicenter randomized controlled trials
should be the method of choice whenever possible.Such
trials are likely to promote more homogeneous presur-
gical strategy among centers and countries.In turn,har-
monization of practice should result in increasing the
yield of successful epilepsy surgery. Dissemination of
current knowledge regarding the eligibility criteria for
entering a presurgical evaluation and the success rate of
epilepsy surgery represents another major challenge in
the field.This should allow more patients with refractory
seizures to benefit from a timely and effective surgical
cure of their devastating disease. ❏
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Cirugía en epilepsia: criterios de elegibilidad
y evaluación prequirúrgica 
La cirugía en la epilepsia se ha beneficiado en los
últimos 20 años de importantes avances, gracias al
desarrollo de las neuroimágenes y del monitoreo
video-electroencefalográfico de larga duración
(EEG). Sin embargo, se mantiene la situación que
sólo una pequeña minoría de potenciales candida-
tos a la cirugía de la epilepsia tendrá acceso a una
exhaustiva evaluación prequirúrgica. Además, este
subgrupo de pacientes es operado después de un
promedio de 20 a 25 años de duración de la epi-
lepsia.  Entre las diversas razones que impiden que
muchos pacientes se beneficien de una oportuna
evaluación prequirúrgica es necesario enfatizar el
papel de la información imprecisa en relación con
los criterios de elegibilidad y la falta de prácticas
estandarizadas. Esta revisión se orienta a proveer
una discusión en profundidad de las visiones actua-
les relacionadas con la definición de candidatos qui-
rúrgicos y el papel de numerosas investigaciones
utilizadas en la evaluación prequirúrgica de pacien-
tes con epilepsia resistente a fármacos.  Los criterios
de elegibilidad requeridos para incluirse en una
evaluación prequirúrgica en 2008 deben ser relati-
vamente flexibles, siempre que el paciente sufra de
crisis convulsivas incapacitantes no relacionadas con
un síndrome epiléptico generalizado idiopático, a
pesar de un apropiado tratamiento con fármacos
antiepilépticos. Sin embargo, la decisión de llevar a
cabo o no una evaluación prequirúrgica debe ser
individualizada y tomar en cuenta la probabilidad
de satisfacer las expectativas del paciente en tér-
minos de su evolución. Estas expectativas necesitan
ser balanceadas con la aparente gravedad de la
condición epiléptica, la posibilidad de conseguir un
tratamiento quirúrgico exitoso y el riesgo de un
deterioro neurológico, cognitivo y psiquiátrico pos-
toperatorio. Se revisarán los papeles y característi-
cas específicas de los tres principales tipos de inves-
tigaciones prequirúrgicas. 
Chirurgie de l’épilepsie : critères d’éligibilité
et évaluation préchirurgicale
Des progrès considérables ont été réalisés lors de
ces 20 dernières années dans le domaine de la chi-
rurgie de l’épilepsie, liés principalement aux déve-
loppements de la neuro-imagerie et du monitorage
à long terme vidéo-électro-encéphalographique.
Cependant, seule une faible minorité des candidats
potentiels à un traitement chirurgical de leur épi-
lepsie ont accès à un tel bilan pré-chirurgical. De
plus, ceux qui en bénéficient sont opérés en
moyenne après 20 à 25 années d’évolution de leur
maladie. Une profonde méconnaissance des critères
d’éligibilité à la chirurgie de l’épilepsie, ainsi qu’une
standardisation insuffisante de ce type de traite-
ment, concourent à cette situation défavorable.
Cette mise au point approfondie vise à présenter
l’état actuel de nos connaissances sur le profil des
candidats à une chirurgie de l’épilepsie, et sur les
moyens à mettre en œuvre pour évaluer avant l’in-
tervention les patients résistants au traitement anti-
épileptique. En 2008, les critères d’éligibilité en vue
de bénéficier d’un bilan préchirurgical doivent être
relativement larges, essentiellement fondés sur la
présence de crises d’épilepsie invalidantes et réfrac-
taires à un traitement médical bien conduit, sans
rapport avec un syndrome d’épilepsie généralisée
idiopathique. Cependant, la décision de réaliser un
tel bilan reste individuelle, et nécessite de prendre
en compte les chances réelles d’aboutir à un traite-
ment chirurgical dont le résultat répondra aux
attentes du patient. Il s’agit notamment de prendre
en compte la sévérité apparente de la maladie, les
chances de guérison des crises par la chirurgie, mais
aussi le risque de complications neurologiques,
cognitives, ou psychiatriques postopératoires.
L’intérêt clinique et la place de chacune des princi-
pales explorations préchirurgicales seront par
ailleurs discutés. Epilepsy surgery - Ryvlin and Rheims Dialogues in Clinical Neuroscience - Vol 10 . No.1 . 2008
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